- Advertisement -

spot_img

TAG

Merck

Personalized mRNA Cancer Vaccine Cuts Melanoma Recurrence Risk by 42% in Landmark Phase 3 Trial

October 23, 2026

An experimental personalized cancer vaccine cut the risk of skin cancer recurrence or death by 42 percent. Pharmaceutical leaders Moderna and Merck presented the...

Latest news

Indian Railways Extends 45-Paise Travel Insurance Scheme to Station Counter Tickets From October 27

October 24, 2026

Tilak Varma and Nitish Kumar Reddy Power Stunning Comeback as India Clinches 4-Wicket Win Over New Zealand

October 24, 2026

Rs 500 Crore Audio Clip Row Exposes Deepening Rift Between BJP and Eknath Shinde’s Shiv Sena

October 24, 2026

Lawrence Bishnoi Gang Targeted Tiger Shroff for Praising Salman Khan, Mumbai Police Tells Court

October 24, 2026

Centre Appoints Senior IAS Officer Sajjan Singh as Jammu and Kashmir’s First AGMUT-Cadre Chief Secretary

October 24, 2026

- Advertisement -

spot_img